Theravance Biopharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
254,611.00
172,434.00
501,096.00
348,566.00
505,276
Total Accounts Receivable
1,273.00
2,129.00
37,154.00
9,722.00
9,362.00
10,673
Inventories
10,406.00
12,546.00
10,005.00
12,220.00
16,830.00
-
Other Current Assets
2,427.00
6,084.00
17,879.00
5,465.00
3,991.00
16,874
Total Current Assets
14,106.00
275,370.00
237,472.00
528,503.00
378,749.00
532,823
Net Property, Plant & Equipment
10,238.00
9,663.00
9,873.00
8,460.00
10,157.00
13,176
Total Investments and Advances
833.00
52,232.00
51,693.00
100,398.00
42,420.00
12,702
Long-Term Note Receivable
-
-
-
-
8,191.00
-
Other Assets
-
506.00
1,078.00
1,893.00
1,883.00
1,534
Total Assets
25,177.00
337,771.00
300,116.00
639,254.00
441,400.00
560,235
Accounts Payable
6,940.00
9,921.00
18,804.00
1,733.00
5,924.00
Other Current Liabilities
29,913.00
31,335.00
30,666.00
47,535.00
56,628.00
Total Current Liabilities
36,853.00
41,256.00
49,470.00
49,268.00
62,552.00
Long-Term Debt
-
-
-
222,676.00
223,746.00
Other Liabilities
5,359.00
6,728.00
7,581.00
17,079.00
39,924.00
Total Liabilities
42,212.00
47,984.00
57,051.00
289,023.00
326,222.00
Common Equity (Total)
17,035.00
289,787.00
243,065.00
350,231.00
115,178.00
Total Shareholders' Equity
17,035.00
289,787.00
243,065.00
350,231.00
115,178.00
Total Equity
17,035.00
289,787.00
243,065.00
350,231.00
115,178.00
Liabilities & Shareholders' Equity
25,177.00
337,771.00
300,116.00
639,254.00
441,400.00
About Theravance Biopharma
View Profile
